Navigation Links
CONRAD executive director to give Guttmacher lecture at Reproductive Health 2009
Date:9/28/2009

Los Angeles, CA On October 2nd, 2009, Henry Gabelnick PhD, Executive Director of The CONRAD Program, will give the prestigious Alan F. Guttmacher lecture at the 2009 Association for Reproductive Health Professionals conference being held in Los Angeles, California. Reproductive Health 2009 is a partnership among the Association of Reproductive Health Professionals, the Planned Parenthood Federation of America National Medical Committee, and the Society of Family Planning. This is the 5th joint annual meeting of these three organizations.

Dr. Gabelnick's lecture, "The Challenge of Providing Dual Protection", draws attention to the increasing need for scientists, government and non-government agencies to fund and develop methods of contraception that also prevents HIV and STI infections. Global figures estimate that there are 76 million unwanted births, 50 million abortions, 536,000 maternal mortalities, 2.7 million new HIV infections and 340 million new cases of curable STIs each year.

A call to action for dual protection began over two decades ago among reproductive health professionals and since then, the CONRAD Program of the Eastern Virginia Medical School has been a leader in developing physical barrier methods of contraception, such as the Female Condom, the SILCS diaphragm, vaginal rings and sponges and chemical spermicides that also have various mechanisms of action that prevent HIV and STIs. CONRAD and other organizations are currently testing combination methods that use both a barrier such as a vaginal ring, impregnated with microbicides.

While USAID, PEPFAR and other organizations are making programmatic progress in terms of funding dual protection methods, there remain scientific challenges and improving prevention technology is largely dependent on funders recognizing that broad spectrum microbicidal activity combined with contraception needs to be funded more vigorously. Dr. Gabelnick will detail current developments
'/>"/>

Contact: Annette Larkin
larkinannette@yahoo.com
703-772-6427
CONRAD
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Front Line Caregiver Coalition Thanks Sens. Conrad, Coleman and Reps. Pomeroy, Capito and Berkley for Leading Bipartisan Hill Effort to Stop Bush Administrations Damaging Medicare Cuts
2. Conrad A. Conrad Elected Chairman of the Board for Rural/Metro Corporation
3. PCMA Statement on Baucus-Conrad Comparative Effectiveness Legislation
4. Conrad J. Heilman to Succeed Joseph S. Tempio as President and CEO of Tunnell Consulting
5. ND Optometrists Partner With U.S. Sens. Conrad and Dorgan, Rep. Pomeroy and Gov. Hoeven in Improving Infant Eye and Vision Care
6. Veteran Medical Malpractice Litigator Gary S. Genovese Re-Joins Conrad & Scherer LLP
7. NCBAs Statement in Response to Senator Conrads Proposal to Reform Health Care
8. Prestige Care, Inc. Takes Over Operational Control of Former Mary Conrad Center
9. Sen. Conrads Health Insurance Co-Ops Wont Provide Affordable Care and Could be Used by the Insurance Industry Against Americans, Says Consumer Watchdog
10. ResMed Names Kieran Gallahue as Chief Executive Officer, Effective January 1, 2008.
11. Align Technology Executive to Present at Upcoming Financial Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... ... September 04, 2015 , ... On the heels of ... the size of its annual health tech innovation program. Now featuring a two-phase ... to compete for cash and prizes to advance their technologies toward commercialization, the ...
(Date:9/4/2015)... ... September 04, 2015 , ... IVF New England, one of the largest and ... Happy Hour" in Manchester for women who wish to learn more about their fertility ... restaurant and lounge, 827 Elm Street, Manchester, NH from 6PM to 7PM , This ...
(Date:9/4/2015)... ... September 04, 2015 , ... ... “Partner of the Year” awards at this year’s Microsoft Worldwide Partner Conference that ... “Partner of the Year” Award Winner for Data Platform services, the 2015 HP ...
(Date:9/4/2015)... ... ... looking for a quick and convenient way to produce a hot remedy for colds. The ... quick and simple way to brew a hot cup of cold remedy when desired. In ... enhance comfort and health. The invention features a novel design that is lightweight, compact and ...
(Date:9/4/2015)... ... September 04, 2015 , ... ... its first neighborhood created specifically for adults with intellectual, developmental and acquired disabilities. ... area and feature 30 cottage or “pocket” homes. In this community, adults will ...
Breaking Medicine News(10 mins):Health News:Insight Product Development Startup Competition on Track to Double Program Impact 2Health News:Insight Product Development Startup Competition on Track to Double Program Impact 3Health News:IVF New England to Host ManchVegas New Hampshire Fertility Happy Hour on October 15, 2015 in Manchester for Women Who Wish to Learn More About Fertility and Egg Freezing 2Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 2Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 4Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 4
... Inc. (Nasdaq: AMLN ) will be presenting ... Monday, January 12, 2009 at 10:00 a.m. PT / ... chief executive officer of Amylin Pharmaceuticals, will be providing ... be webcast, and a recording will be made available ...
... ONXX ) today announced that it has acquired ... potent, and selective inhibitor of Janus Kinase 2 (JAK2), and ... in Singapore. Under the terms of the agreement, Onyx ... (designated by Onyx as ONX 0803) and SB1578 (designated by ...
... Calif. and SAN DIEGO, Jan. 6 BioMarin,Pharmaceutical Inc. ... Company,(Nasdaq: LJPC ) announced today that they ... La Jolla,s investigational drug for,lupus nephritis, in the United ... the Asia Pacific region. Following a successful Phase 3,trial, ...
... of the wrist at 3T is an effective way to detect ... according to a study performed at Neuroskeletal Imaging in Merritt Island, ... 3T MR and arthroscopy; 51 tears were found on arthroscopy. 41 ... resolution with 3T MRI is good. We are able to see ...
... MR arthrography of the shoulder allows physicians to better ... to determine whether or not surgery is needed, according ... Island, Florida. , The study included 150 patients ... of the shoulder. "We did the study to see ...
... release is available in French . ... an 80-year old drug once used to treat diarrhea ... of Alzheimer,s, Parkinson,s and Huntington,s diseases. Scientists, however, had ... a single compound could have such similar effects on ...
Cached Medicine News:Health News:Onyx Pharmaceuticals Acquires Option to License Novel Highly Specific JAK2 Inhibitors From S*BIO 2Health News:Onyx Pharmaceuticals Acquires Option to License Novel Highly Specific JAK2 Inhibitors From S*BIO 3Health News:Onyx Pharmaceuticals Acquires Option to License Novel Highly Specific JAK2 Inhibitors From S*BIO 4Health News:BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent 2Health News:BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent 3Health News:BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent 4Health News:BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent 5Health News:BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent 6Health News:BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent 7Health News:BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent 8Health News:MR arthrography is more accurate than MR in diagnosing shoulder tears 2Health News:Old gastrointestinal drug slows aging, McGill researchers say 2
(Date:9/4/2015)... plc (NYSE: AGN ) a leading global pharmaceutical company, ... of Allergan, will provide an overview and update of the ... in New York, NY . ... will take place on Thursday, September 17, 2015 at 10:35 ... East 42nd Street, New York, NY ...
(Date:9/4/2015)... DUBLIN , Sep. 04, 2015 ... addition of the "Investigation Report on China,s Sodium Ibandronate ... registered and used in the clinic under the trade name ... Austria in 1996, sodium ibandronate was approved ... daily treatment of osteoporosis under the trade name of Boniva. ...
(Date:9/3/2015)... 3, 2015  Cipla, a global pharmaceutical company which ... of all patients, today announced that its UK arm, ... two US-based companies, InvaGen Pharmaceuticals Inc., and Exelan Pharmaceuticals ... is valued at $550 million and will be an ... is over $200 million for the year ended Dec ...
Breaking Medicine Technology:Allergan to Present at Morgan Stanley Global Healthcare Conference 2015 2Allergan to Present at Morgan Stanley Global Healthcare Conference 2015 3Investigation Report on China's Sodium Ibandronate Market 2010-2019 2Cipla to acquire 100% of generic businesses in US for $550M 2Cipla to acquire 100% of generic businesses in US for $550M 3Cipla to acquire 100% of generic businesses in US for $550M 4Cipla to acquire 100% of generic businesses in US for $550M 5
... DataPro is a smart, sophisticated and compact medium ... cost effective chemistry analyser in its class! It ... do 230 tests per hour. The DataPro runs ... a normal biochemistry laboratory and runs a wide ...
Ademtechs Magnetic Beads are produced by encapsulation of a magnetic oil (patented technology). The magnetic content, uniform particle size, mono-dispersion properties, and the high surface area allo...
... Our manufacturing process ... flux-density nanocrystals ensuring magnetic ... allied with the rigid ... no magnetic aggregation occurs ...
BioVintages Biotin-Trapper™ Streptavidin Magnetic Beads (1 mm - 2 mm) are designed for single-step capture of biotinylated molecules such as DNA, RNA or protein from cell lysates or hybridizatio...
Medicine Products: